Delivery Order SPE2DR25D3103-SPE2DR26F9G09
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,856.70 to AmerisourceBergen Drug Corp for the supply of Sacubitril-Valsartan 24-26 mg in quantities of 60 tablets. This competitively awarded, firm fixed-price delivery order is scheduled for completion by November 17, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract carries no set-aside designation, indicating that AmerisourceBergen Drug Corp competed against...
- The Defense Logistics Agency awarded a delivery order valued at $18,186.68 to AmerisourceBergen Drug Corp for the supply of Sacubitril-Valsartan 24-26 mg tablets (60 count) on September 9, 2025, with a completion date of September 10, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Sacubitril-Valsartan 24-26 mg tablets (60-count) valued at $2,202.57. This is a firm fixed-price, non-set-aside contract with performance to be completed by September 16, 2025, and fulfillment occurring at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The award represents a delivery order under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $2,868.48 delivery order to AmerisourceBergen Drug Corp for Sacubitril-Valsartan 24-26 mg tablets (60-count supply) on September 24, 2025, with an ultimate completion date of September 25, 2025. This firm fixed-price, non-set-aside contract will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills this order as a child delivery...
- The Defense Logistics Agency awarded a delivery order valued at $3,938.25 to AmerisourceBergen Drug Corp for Sacubitril-Valsartan 24-26 mg tablets (60-count supply) on September 22, 2025, with an ultimate completion date of September 23, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 180 tablets of Sacubitril-Valsartan 97-103 mg, with a contract ceiling value of $1,066.02. This is a firm fixed-price delivery order with an award date of September 5, 2025, and ultimate completion date of September 8, 2025. The contract was competitively awarded without set-aside designation, and performance will be executed at AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $15,166.08 for Sacubitril-Valsartan 97-103 mg tablets (60-count) on September 22, 2025, with completion scheduled for September 23, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $12,741.44 to AmerisourceBergen Drug Corp for the supply of Sacubitril-Valsartan 24-26 mg in quantities of 60 tablets. This competitively awarded, firm fixed-price delivery order was issued on September 17, 2025, with an ultimate completion date of September 18, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $6,183.25 to AmerisourceBergen Drug Corp for Sacubitril-Valsartan 49-51 mg tablets (60-count supply) on November 4, 2025, with completion scheduled for November 5, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition to the Conshohocken, Pennsylvania-based pharmaceutical distributor. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Sacubitril-Valsartan 24-26 mg tablets in a quantity of 180 units, valued at $19,641.70. This delivery order is issued under a firm fixed-price contract type with no set-aside designation, indicating the award was competitively procured. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9G09Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,148.34 to AmerisourceBergen Drug Corp for Sacubitril-Valsartan 24-26 mg tablets (180-count supply) with a firm fixed price structure. This non-competitive delivery order, issued on November 17, 2025, is scheduled for completion by November 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of pharmaceutical supply support under AmerisourceBergen's existing contract relationship with the federal government. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vehicle serves as a comprehensive global pharmaceutical support contract enabling the distributor to supply a broad range of medications, vaccines, medical devices, and specialized healthcare commodities to support military healthcare programs and other federal health systems. As a major pharmaceutical distributor, AmerisourceBergen maintains a demonstrated capability to fulfill federal medical procurement requirements and regularly supplies critical medications across multiple therapeutic domains to defense and veteran healthcare customers.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/17/25 |